| 2014 | | A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome. | 손영배 |
| 1998 | | Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 2003 | | Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? | 김명욱, 김영배, 김진홍, 유병무, 조성원, 한상욱, 함기백 |
| 2021 | | Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study | 허중연 |
| 2003 | | Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice. | 김진홍, 유병무, 이기명, 조성원, 주희재, 함기백 |
| 1995 | | Factor VNew Brunswick: Ala221-to-Val substitution results in reduced cofactor activity. | 김효철 |
| 1997 | | Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. | 강엽, 윤지원 |
| 1998 | | Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. | 김진홍, 이광재, 조성원, 함기백 |
| 2014 | | Phosphorylation of a central clock transcription factor is required for thermal but not photic entrainment. | 김은영 |
| 2004 | | Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats. | 함기백 |
| 1998 | | Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 1997 | | Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. | 김영수, 김진홍, 윤정구, 조성원, 함기백 |
| 2023 | | Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea | 김순선 |
| 2011 | | The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells | 박용예, 조혜성 |
| 2022 | | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment | 김영롱, 유진세, 허중연 |
